Amarin Corp Plc (AMRN)

[SovereignNinja5]

Our business model is changing. We get better margins OUS so we want volume. The USA market will be the same. Better margin more volume. Fenofibrates/Fubrares are wrongly prescribed 11 million a year to Two million patients in USA alone. What % of that business do we need to be worth a few billion more? Things getting clearer yet for you? Bolt on with carry forward tax losses and a pile of cash to fund a second IFU. Take your pick on that with EMT2 data or how about LP(a) in the CVD space? Do you follow all the science over the past few years Do More Charity puts out?